Kuznicki Michelle L, Robertson Sharon E, Hakam Ardeshir, Shahzad Mian M
Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL, USA.
Department of Gynecologic Oncology, University of South Florida, Tampa, FL, USA.
Gynecol Oncol Rep. 2017 Sep 29;22:64-68. doi: 10.1016/j.gore.2017.09.012. eCollection 2017 Nov.
Uterine tumors resembling ovarian sex cord tumors (UTROSCTs) are rare and commonly characterized as benign tumors, with infrequent reports of metastasis and recurrence. Treatment recommendations have not been well established, particularly for more advanced cases. We present the first reported death from a metastatic UTROSCT, summarize the available literature, and describe characteristics common to UTROSCTs with aggressive features. In this case, a 49-year-old woman presented with abdominal distension and pain; initial imaging and diagnostic workup suggested metastatic epithelial ovarian cancer to be the cause. The patient subsequently underwent neoadjuvant chemotherapy followed by optimal cytoreductive surgery and adjuvant chemotherapy. Final pathology revealed UTROSCT with omental and peritoneal metastases. She then underwent adjuvant chemotherapy with subsequent recurrence and died 15 months after her initial diagnosis. Our analysis of this case and the available literature led us to identify pathologic risk factors that may help predict aggressive UTROSCT behavior.
子宫性索样肿瘤(UTROSCT)较为罕见,通常被认为是良性肿瘤,转移和复发的报道较少。治疗建议尚未明确确立,尤其是对于更晚期的病例。我们报告了首例转移性UTROSCT死亡病例,总结了现有文献,并描述了具有侵袭性特征的UTROSCT的共同特征。在本病例中,一名49岁女性出现腹胀和腹痛;初始影像学检查和诊断性检查提示转移性上皮性卵巢癌为病因。患者随后接受了新辅助化疗,随后进行了最佳减瘤手术和辅助化疗。最终病理显示为伴有大网膜和腹膜转移的UTROSCT。她随后接受了辅助化疗,但随后复发,并在初次诊断后15个月死亡。我们对该病例和现有文献的分析使我们确定了可能有助于预测侵袭性UTROSCT行为的病理危险因素。